Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]
NCT ID: NCT03265145
Last Updated: 2022-06-14
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
714 participants
INTERVENTIONAL
2017-09-20
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The secondary objectives of this study include:
1. To compare the annual rate of moderate or severe COPD exacerbations for patients on Stiolto Respimat with patients on triple therapy.
2. To compare the time to first severe COPD exacerbation in both treatment arms.
3. To compare the annual rate of severe COPD exacerbations in both treatment arms.
4. To compare the proportion of patients with moderate or severe COPD exacerbations in both treatment arms.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD
NCT00240435
Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02175342
Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)
NCT06234345
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent Asthma
NCT01316380
Tiotropium / Respimat One-Year Study
NCT00168831
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stiolto Respimat
Stiolto Respimat
Duration - 12 months
ICS plus LABA plus LAMA (triple therapy)
ICS (Inhaled Corticosteroid) plus LABA (Long-Acting Beta Agonist) plus (Long-Acting Muscarinic Antagonist)
ICS (Inhaled Corticosteroid) (Triple therapy)
Duration - 12 months
LABA (Long-Acting Beta Agonist) (Triple therapy)
Duration - 12 months
LAMA (Long-Acting Muscarinic Antagonist) (Triple therapy)
Duration - 12 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stiolto Respimat
Duration - 12 months
ICS (Inhaled Corticosteroid) (Triple therapy)
Duration - 12 months
LABA (Long-Acting Beta Agonist) (Triple therapy)
Duration - 12 months
LAMA (Long-Acting Muscarinic Antagonist) (Triple therapy)
Duration - 12 months
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently on one of the following maintenance therapies:
* LAMA monotherapy
* LABA monotherapy
* ICS/LABA (FDC)
* Physician determination that patient is not controlled on current pharmacotherapy
* Adult patient 40 years of age or older at time of study enrollment
* Willingness and ability to understand and provide documented Informed Consent Form (ICF) and Health Insurance Portability and Accountability Act (HIPAA) Authorization Form prior to commencement of any study required assessments, either directly or through Legally Authorized Representative.
Exclusion Criteria
* Contraindication to any study medications (LAMA, LABA or ICS)
* Documented diagnosis of current asthma
* Pregnant or nursing women
* Women of childbearing potential are not restricted in this trial, however it is expected that the investigator will assess the risks and benefits of the assigned treatment as per the product label(s) and discuss this with any women of childbearing potential prior to providing the patient with the prescription for the assigned treatment.
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Carelon Research
OTHER
Boehringer Ingelheim
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pulmonary Associates of Mobile, PC
Mobile, Alabama, United States
Healthscan Clinical Trials LLC
Montgomery, Alabama, United States
HealthScan Research
Montgomery, Alabama, United States
Diamond Childrens Medical Center
Tucson, Arizona, United States
CareMore Apple Valley Care Center
Apple Valley, California, United States
HealthCare Partners
Commerce, California, United States
Advanced Research Center, Inc.
Murrieta, California, United States
Newport Native MD, Inc
Newport Beach, California, United States
Aureus Medical Group, Inc
Rancho Cucamonga, California, United States
Capital Allergy and Respiratory Disease Center
Roseville, California, United States
Paloma Medical Group
San Juan Capistrano, California, United States
Adnab Research/Prestige Care Physician
Torrance, California, United States
Pulmonary and Sleep of Tampa Bay
Brandon, Florida, United States
Innovative Research of West Florida, Inc.
Clearwater, Florida, United States
Saint Francis Sleep, Allergy and Lung Institute, LLC
Clearwater, Florida, United States
Cohen Medical Research Associates, LLC
Delray Beach, Florida, United States
Gary J. Richmond, M.D., PA
Fort Lauderdale, Florida, United States
Medical Research of Central Florida
Leesburg, Florida, United States
Florida Lung and Sleep Associates
Lehigh Acres, Florida, United States
TRY Research
Maitland, Florida, United States
Pro Live Medical Research
Miami, Florida, United States
Advanced Research for Health Improvement, LLC
Naples, Florida, United States
Oviedo Medical Research
Oviedo, Florida, United States
Bassetti Medical Research Inc
Sebring, Florida, United States
Pasadena Ctr for Medical Rsrch
St. Petersburg, Florida, United States
John Suen MD PA
Vero Beach, Florida, United States
Gwinnett Research Institute
Buford, Georgia, United States
Pulmonary and Sleep Specialists, PC
Decatur, Georgia, United States
DC Pulmonary Medicine
Marietta, Georgia, United States
Southern IL Clinical Rsrch Ctr
O'Fallon, Illinois, United States
American Health Network of Indiana, LLC
Franklin, Indiana, United States
American Health Network of Indiana, LLC
Greenfield, Indiana, United States
The LaPorte County Institute for Clinical Research
Michigan City, Indiana, United States
Ball Memorial Hospital
Muncie, Indiana, United States
American Health Network
New Albany, Indiana, United States
Kentucky Lung Clinic
Georgetown, Kentucky, United States
Pulmonary and Sleep Clinic PLLV
Hopkinsville, Kentucky, United States
Johns Hopkins Hospital
Baltimore, Maryland, United States
Pulmonary and Critical Care Associates of Baltimore
Bel Air, Maryland, United States
Pulmonary and Critical Care Associates of Baltimore
Towson, Maryland, United States
Lahey Hospital and Medical Center
Burlington, Massachusetts, United States
Vida Clinical Studies
Dearborn, Michigan, United States
Flint Clinical Research
Flint, Michigan, United States
Mercy Surgery Center
Springfield, Missouri, United States
Clayton Sleep Institute
St Louis, Missouri, United States
Jubilee Clinical Research, Inc
Las Vegas, Nevada, United States
Shore Pulmonary, PA
Ocean City, New Jersey, United States
Bassett Medical Center
Cooperstown, New York, United States
Pulmonary Health Physicians
Fayetteville, New York, United States
Feinstein Institute for Medical Research
New Hyde Park, New York, United States
Lenox Hill Hospital
New York, New York, United States
Orchard Park Family Practice
Orchard Park, New York, United States
American Health Research, Inc.
Charlotte, North Carolina, United States
Clinical Research of Gastonia
Gastonia, North Carolina, United States
Coastal Carolina Health Care, P.A.
New Bern, North Carolina, United States
Tabor City Family Medicine
Tabor City, North Carolina, United States
Goshen Medical Center
Whiteville, North Carolina, United States
Southeastern Research Center
Winston-Salem, North Carolina, United States
Catherine LaRuffa, MD, Inc.
Blanchester, Ohio, United States
Valley Medical Primary Care
Centerville, Ohio, United States
University Hospitals of Cleveland
Cleveland, Ohio, United States
Midwest Pulmonary and Sleep Research
Dayton, Ohio, United States
Ohio Sleep and Pulmonary Center
Englewood, Ohio, United States
Prestige Clinical Research
Franklin, Ohio, United States
Robert Santiago MD, Inc.
Galion, Ohio, United States
Pulmonary, Critical Care and Sleep Medicine Associates
Hamilton, Ohio, United States
Wells Inst for Hlth Awareness
Kettering, Ohio, United States
Pulmonary Medicine
South Euclid, Ohio, United States
Toledo Clinic Incorporated
Toledo, Ohio, United States
Ohio Clinical Research, LLC
Willoughby Hills, Ohio, United States
Comprehensive Internal Medicine, Inc.
Wooster, Ohio, United States
Preferred Primary Care Phys
Pittsburgh, Pennsylvania, United States
Preferred Primary Care Phys
Pittsburgh, Pennsylvania, United States
Frontier Clinical Research, LLC
Scottdale, Pennsylvania, United States
Frontier Clinical Research LLC
Smithfield, Pennsylvania, United States
Preferred Primary Care Phys
Uniontown, Pennsylvania, United States
Carolina Medical Research
Clinton, South Carolina, United States
Main Street Physicians Care
Little River, South Carolina, United States
Family Medicine of SayeBrook
Myrtle Beach, South Carolina, United States
Houston Pulmonary Sleep Allergy and Asthma Associates
Cypress, Texas, United States
Texas Health Physicians Group
Dallas, Texas, United States
North Texas Lung & Sleep Clnc
Fort Worth, Texas, United States
SMS Clinical Research
Mesquite, Texas, United States
San Marcos Family Medicine
San Marcos, Texas, United States
Texarkana Clinical Research
Texarkana, Texas, United States
Chesapeake Pulmonary and Critical Care
Chesapeake, Virginia, United States
Richmond Family Practice
Richmond, Virginia, United States
MultiCare Institute
Cheney, Washington, United States
Western Washington Medical Grp
Everett, Washington, United States
Pulmonary and Critical Care Associates, SC
Cudahy, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1237-0064
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.